FEYAX
Price
$29.48
Change
-$0.02 (-0.07%)
Updated
Aug 15 closing price
Net Assets
4.94B
FIQCX
Price
$29.71
Change
-$0.02 (-0.07%)
Updated
Aug 15 closing price
Net Assets
4.94B
Interact to see
Advertisement

FEYAX vs FIQCX

Header iconFEYAX vs FIQCX Comparison
Open Charts FEYAX vs FIQCXBanner chart's image
Fidelity Advisor Asset Manager 85% A
Price$29.48
Change-$0.02 (-0.07%)
VolumeN/A
Net Assets4.94B
Fidelity Advisor Asset Manager 85% Z
Price$29.71
Change-$0.02 (-0.07%)
VolumeN/A
Net Assets4.94B
FEYAX vs FIQCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FEYAX vs. FIQCX commentary
Aug 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FEYAX is a Buy and FIQCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FEYAX (4.94B) and FIQCX (4.94B) have equal amount of cash in the bank . FIQCX pays higher dividends than FEYAX: FIQCX (1.45) vs FEYAX (1.07). FEYAX was incepted earlier than FIQCX: FEYAX (19 years) vs FIQCX (7 years). FEYAX (0.94) is less costly to investors than FIQCX (0.57). FEYAX (16.00) and FIQCX (16.00) have comparable annual turnover. FEYAX (0) and FIQCX (0) have matching initial minimum investment requirements. FIQCX (13.36) and FEYAX (12.96) have marching annual gain over last year. FIQCX return over 5 years is better than : 52.41 vs. FEYAX (49.56).
FEYAXFIQCXFEYAX / FIQCX
Total Expense Ratio0.940.57165%
Annual Report Gross Expense Ratio0.940.57165%
Fund Existence19 years7 years-
Gain YTD12.98413.25798%
Front Load6%N/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets4.94B4.94B100%
Annual Yield % from dividends1.071.4574%
Returns for 1 year12.9613.3697%
Returns for 3 years32.1233.6595%
Returns for 5 years49.5652.4195%
Returns for 10 years84.67N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GAHPX27.41N/A
N/A
Goldman Sachs Emerging Markets Eq P
PRDGX83.83N/A
N/A
T. Rowe Price Dividend Growth
WFDRX33.31N/A
N/A
Allspring SMID Cap Growth Fund - Cl R6
ICTTX15.11N/A
N/A
ICON Health and Information Tech Inv
MLNCX25.72N/A
N/A
Morgan Stanley Instl Glbl Concntr C